Consequently, the interplay between Aβ/tau pathologies, complement activation, and cytokine signaling establishes a self-perpetuating cycle that drives AD progression through sustained neuroinflammation and synaptic loss. This evidence concerns the gene MAPT and Alzheimer disease.